Smiths Group PLC Director Responsibilities (3415A)
February 01 2022 - 8:59AM
UK Regulatory
TIDMSMIN
RNS Number : 3415A
Smiths Group PLC
01 February 2022
1 February 2022
SMITHS GROUP PLC ("Smiths")
DIRECTOR RESPONSIBILITIES
In accordance with the terms of the shareholders agreement
entered into with ICU Medical, Inc. ('ICU') on the sale of Smiths
Medical, Smiths is pleased to announce that Bill Seeger, a
non-executive Director of Smiths, will join the ICU Board and Audit
and Compliance Committee as Smiths' nominee with effect from 1
February 2022. Bill Seeger's ongoing appointment will be subject to
ICU shareholder approval at each annual ICU shareholder
meeting.
Bill Seeger will not receive a fee from Smiths or ICU for his
role as an ICU Director or Audit and Compliance Committee member.
Biographic details can be found on Smiths' website www.smiths.com
.
There is no further information required to be disclosed
pursuant to LR 9.6.11(3) or LR9.6.14(2).
Enquiries:
Matthew Whyte
Group Company Secretary
+44 (0) 20 7004 1600
+44 (0) 7775 982 879
Matthew.whyte@smiths.com
Jemma Spalton
Investor Relations Director
+44 (0) 20 7004 1600
+44 (0) 7867 390 350
Jemma.spalton@smiths.com
Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11
About Smiths Group
For over 170 years, Smiths Group has been pioneering progress by
improving the world through smarter engineering. We serve millions
of people every year, to help create a safer, more efficient and
better-connected world, across four major global markets: Energy,
General Industry, Security & Defence, and Aerospace. Listed on
the London Stock Exchange, Smiths employs c.14,600 colleagues in
over 50 countries. For more information visit www.smiths.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCUARURUKUURAR
(END) Dow Jones Newswires
February 01, 2022 08:59 ET (13:59 GMT)
Smiths (LSE:SMIN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Smiths (LSE:SMIN)
Historical Stock Chart
From Jul 2023 to Jul 2024